XLO: Xilio Therapeutics Inc
今日XLO汇率已更改0.00%。当日,交易品种以低点0.63和高点0.65进行交易。
关注Xilio Therapeutics Inc动态。实时报价将帮助您快速应对市场变化。通过在不同的时间周期之间切换,您可以按分钟、小时、天、周和月监控汇率趋势和动态。使用这些信息来预测市场变化并做出明智的交易决策。
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
XLO新闻
- 西利奥治疗公司从权证行权中获得3580万美元
- Xilio Therapeutics secures $35.8 million from warrant exercises
- Xilio Therapeutics报告从B系列权证行权中获得3580万美元收益
- Xilio Development Q3 每股收益 逊于预期, 营收 超出预期
- Xilio Development earnings missed by $0.06, revenue topped estimates
- Xilio Therapeutics, Inc. (XLO) Reports Q3 Loss, Misses Revenue Estimates
- BioXcel Therapeutics, Inc. (BTAI) Reports Q3 Loss, Misses Revenue Estimates
- Xilio Therapeutics, Inc. (XLO) Discusses Phase 2 Vilastobart Combination Data and High Plasma TMB as Predictive Biomarker in MSS mCRC - Slideshow (NASDAQ:XLO) 2025-11-11
- Xilio Therapeutics, Inc. (XLO) Discusses Phase 2 Vilastobart Combination Data and High Plasma TMB as Predictive Biomarker in MSS mCRC Transcript
- Xilio presents promising data for tumor-activated immunotherapies
- Xilio reports 40% response rate in colorectal cancer treatment study
- Xilio to present vilastobart phase 2 data at SITC annual meeting
- Xilio Therapeutics将于周一转至纳斯达克资本市场交易
- Xilio Therapeutics to transfer listing to Nasdaq Capital Market on Monday
- Xilio initiates phase 2 trial for tumor-activated IL-12 therapy
- Xilio Development earnings missed by $0.06, revenue topped estimates
- Xilio Therapeutics, Inc. (XLO) Reports Q2 Loss, Misses Revenue Estimates
- Leerink Partners initiates coverage on Xilio Therapeutics stock with Outperform rating
- Xilio Therapeutics expands board, elects new director
- Xilio Therapeutics appoints oncology veteran Akintunde Bello to board
- Xilio Therapeutics Announces Closing of $50.0 Million Public Offering
- Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Nasdaq Edges Higher; ISM Manufacturing PMI Falls In May - Applied Digital (NASDAQ:APLD), Lyra Therapeutics (NASDAQ:LYRA)
- Dow Dips Over 300 Points; Campbell's Posts Upbeat Earnings - The Campbell's (NASDAQ:CPB), InMed Pharmaceuticals (NASDAQ:INM)
常见问题解答
XLO股票今天的价格是多少?
Xilio Therapeutics Inc股票今天的定价为0.64。它在0.63 - 0.65范围内交易,昨天的收盘价为0.64,交易量达到144。XLO的实时价格图表显示了这些更新。
Xilio Therapeutics Inc股票是否支付股息?
Xilio Therapeutics Inc目前的价值为0.64。股息政策取决于公司,而投资者也会关注-9.86%和USD。实时查看图表以跟踪XLO走势。
如何购买XLO股票?
您可以以0.64的当前价格购买Xilio Therapeutics Inc股票。订单通常设置在0.64或0.94附近,而144和-1.54%显示市场活动。立即关注XLO的实时图表更新。
如何投资XLO股票?
投资Xilio Therapeutics Inc需要考虑年度范围0.62 - 1.70和当前价格0.64。许多人在以0.64或0.94下订单之前,会比较-1.54%和。实时查看XLO价格图表,了解每日变化。
Xilio Therapeutics Inc股票的最高价格是多少?
在过去一年中,Xilio Therapeutics Inc的最高价格是1.70。在0.62 - 1.70内,该股波动显著,与相比有助于发现阻力位。使用实时图表跟踪Xilio Therapeutics Inc的绩效。
Xilio Therapeutics Inc股票的最低价格是多少?
Xilio Therapeutics Inc(XLO)的最低价格为0.62。将其与当前的0.64和0.62 - 1.70进行比较,可以发现潜在的长期切入点。观看XLO在图表上的实时走势以获取更多详细信息。
XLO股票是什么时候拆分的?
Xilio Therapeutics Inc历史上曾经历过股票拆分。这些变化在公司行动后的、0.64和-9.86%中可见。
- 前一天收盘价
- 0.64
- 开盘价
- 0.65
- 卖价
- 0.64
- 买价
- 0.94
- 最低价
- 0.63
- 最高价
- 0.65
- 交易量
- 144
- 日变化
- 0.00%
- 月变化
- -1.54%
- 6个月变化
- 0.00%
- 年变化
- -9.86%
- 实际值
- 预测值
- 前值